Autopsy report · NCT04203381

Skeletal Health and Bone Marrow Composition Among Youth

“Funding was terminated.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months before it started.
• Ran for about 5 years 6 months before it stopped.
• 78 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Amy DiVasta, MD

Sponsor type

University, hospital or other

Conditions

Gender Dysphoria in Children; Puberty; Bone Development

Interventions

GnRH Agonist

Participants

78

Sites

2

Countries

United States

Trials that died the same way

• Vancomycin for Primary Sclerosing Cholangitis
  “Funding terminated” (93% match in meaning)
• Mindfulness Intervention for Caregivers of Autism in Rural Environments
  “Funding was terminated, seeing new funding.” (91% match in meaning)
• Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis
  “Souces of funding have been terminated” (88% match in meaning)
• Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery
  “Funding terminated by funding source.” (87% match in meaning)
• Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
  “Terminated due to loss of funding” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.